2022 | | S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus | 김지원, 김현아, 서창희, 정주양 |
2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
2021 | | Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review | 김지원, 김현아, 서창희, 정주양 |
2021 | | Salivary immunoglobulin gamma-3 chain c is a promising noninvasive biomarker for systemic lupus erythematosus | 김현아, 서창희, 정주양 |
2020 | | Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea | 김현아, 서창희, 정주양 |
2020 | | SEASONAL VARIATIONS AND ASSOCIATED FACTORS OF GOUT ATTACKS: A PROSPECTIVE MULTICENTER STUDY IN SOUTH KOREA | 김현아, 서창희, 정주양 |
2024 | | Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
2022 | | Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus | 김지원, 김현아, 서창희, 정주양 |
2020 | | Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity | 서창희 |
2022 | | Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report | 김지원, 김현아, 서창희, 정주양 |
2021 | | Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease | 김지원, 김현아, 서창희, 정주양 |
2020 | | Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis | 김지원, 서창희 |
2020 | | The alphaC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases | 김순선, 서창희, 정재연 |
2021 | | The assessment of muscle mass and function in patients with long-standing rheumatoid arthritis | 김지원, 김춘자, 김현아, 서창희, 정주양 |
2019 | | The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
2023 | | The transcription factor Mef2d regulates B:T synapse–dependent GC-TFH differentiation and IL-21–mediated humoral immunity | 김지원, 서창희 |
2022 | | Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus | 김현아, 서창희, 정주양 |
2021 | | Toll‐like receptor signaling inhibitory peptide improves inflammation in animal model and human systemic lupus erythematosus | 서창희 |
2020 | | Trabecular Bone Score Is a Useful Parameter for the Prediction of Vertebral Fractures in Patients With Polymyalgia Rheumatica | 김현아, 서창희, 정윤석, 정주양, 최용준 |
2022 | | Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis | 서창희 |
2023 | | Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry | 김지원, 김현아, 서창희, 정주양 |